Risk factors for hyperechogenic pancreas on endoscopic ultrasound: A case-control study

Pancreas

Volumn 38, Issue 6, 2009, Pages 672-675

  Al Haddad, Mohammad ^a   Khashab, Mouen ^a   Zyromski, Nicholas ^a   Pungpapong, Surakit ^b   Wallace, Michael B ^b   Scolapio, James ^b   Woodward, Timothy ^b   Noh, Kyung ^b   Raimondo, Massimo ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Hyperechogenic pancreas; Metabolic risk factors; Pancreatic steatosis

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EVALUATION; FATTY LIVER; FEMALE; HUMAN; HYPERECHOGENIC PANCREAS; LIVER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PANCREAS; PANCREAS DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SEX; SPLEEN;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; ENDOSONOGRAPHY; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PANCREAS; PANCREATIC DISEASES; RISK FACTORS;

EID: 68949132763     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181a9d5af     Document Type: Article

References (38)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
2. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
4. Khashab MA, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep. 2008;10:73-80.
5. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford). 2007;9:312-318.
6. Ogilvie RF. The islands of Langerhans in 19 cases of obesity. J Pathol. 1933;37:473-481.
7. Glaser J, Stienecker K. Pancreas and aging: a study using ultrasonography. Gerontology. 2000;46:93-96.
8. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand [A]. 1978;86A:367-373.
9. Worthen NJ, Beabeau D. Normal pancreatic echogenicity: relation to age and body fat. AJR Am J Roentgenol. 1982;139:1095-1098.
10. Katz DS, Hines J, Math KR, et al. Using CT to reveal fat-containing abnormalities of the pancreas. AJR Am J Roentgenol. 1999;172:393-396.
11. Matsumoto S, Mori H, Miyake H, et al. Uneven fatty replacement of the pancreas: evaluation with CT. Radiology. 1995;194:453-458.
12. Catalano MF, Lahoti S, Geenen JE, et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc. 1998;48:11-17.
13. Hawes RH. Endoscopic ultrasound. Gastrointest Endosc Clin N Am. 2000;10:161-174.
14. Lambert R, Caletti G, Cho E, et al. International workshop on the clinical impact of endoscopic ultrasound in gastroenterology. Endoscopy. 2000;32:549-584.
15. Buscail L, Escourrou J, Moreau J, et al. Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERCP. Pancreas. 1995;10:251-257.
16. Siddiqi AJ, Miller F. Chronic pancreatitis: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28:384-394.
17. Goldblatt MI, Swartz-Basile DA, Al-Azzawi HH, et al. Nonalcoholic fatty gallbladder disease: the influence of diet in lean and obese mice. J Gastrointest Surg. 2006;10:193-201.
18. Mathur A, Al-Azzawi HH, Lu D, et al. Steatocholecystitis: the influence of obesity and dietary carbohydrates. J Surg Res. 2008;147:290-297.
19. Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford). 2007;9:92-97.
20. Sobhonslidsuk A, Jongjirasiri S, Thakkinstian A, et al. Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. World J Gastroenterol. 2007;13:3614-3618.
21. Solis Herruzo JA, Garcia Ruiz I, Perez Carreras M, et al. Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction. Rev Esp Enferm Dig. 2006;98:844-874.
22. Chtioui H, Semela D, Ledermann M, et al. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver Int. 2007;27:764-771.
23. Emery MG, Fisher JM, Chien JY, et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology. 2003;38:428-435.
24. Ikejima K, Okumura K, Kon K, et al. Role of adipocytokines in hepatic fibrogenesis. J Gastroenterol Hepatol. 2007;22(suppl 1):S87-S92.
25. Wilson JS, Colley PW, Sosula L, et al. Alcohol causes a fatty pancreas. A rat model of ethanol-induced pancreatic steatosis. Alcohol Clin Exp Res. 1982;6:117-121.
26. Martinez J, Johnson CD, Sanchez-Paya J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206-209.
27. Papachristou GI, Papachristou DJ, Avula H, et al. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology. 2006; 6:279-285.
28. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83:461S-465S.
29. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005; 19:547-566.
30. Vuppalanchi R, Marri S, Kolwankar D, et al. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol. 2005;39:237-242.
31. Zyromski NJ, Mathur A, Yancey K, et al. Non-alcoholic steatopancreatitis (NASP) - obesity or leptin? J Surg Res. 2007;137:222.
32. Hu ZW, Guo JW, Deng XL. Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26:853-855.
33. Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol. 2006;101:2629-2640.
34. Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058-1064.
35. Patel AV, Rodriguez C, Bernstein L, et al. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev. 2005;14:459-466.
36. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health - AARP Diet and Health Cohort. Am J Epidemiol. 2008; 167:586-597.
37. Paulsen SD, Nghiem HV, Negussie E, et al. Evaluation of imaging-guided core biopsy of pancreatic masses. AJR Am J Roentgenol. 2006;187:769-772.
38. DeWitt J, McGreevy K, LeBlanc J, et al. EUS-guided Trucut biopsy of suspected nonfocal chronic pancreatitis. Gastrointest Endosc. 2005;62:76-84.